Bernard Bonnotte

Is there still a place for "old therapies" in the management of immune thrombocytopenia?

B. Bonnotte, B. Godeau, S. Audia, 2016, La Revue de medecine interne.

[Immune thrombocytopenia: From pathogenesis to treatment].

M. Mahévas, S. Audia, Bernard Bonnotte, 2020, La Revue de medecine interne.

This information is current as ImmunogenicityGrowth and Decreases Cell Infiltration but Enhances (Facilitates) Cell Line Increases Intratumoral Dendritic Transfection into a Rodent Tumor α MIP-3

R. Vile, N. Larmonier, M. Crittenden, 2013 .

Cytotoxic and antigen presenting functions of T helper-1-activated dendritic cells

N. Larmonier, Bernard Bonnotte, Emmanuel Katsanis, 2012, Oncoimmunology.

Tumor-infiltrating dendritic cells are defective in their antigen-presenting function and inducible B7 expression. A role in the immune tolerance to antigenic tumors.

B. Bonnotte, N. Favre, M. Moutet, 1997, Advances in experimental medicine and biology.